Member Info for beinthelead

This

Thanks.

“ DHSC will prioritise certain applications where necessary…”

“We knew by January we had a number of tests that were highly effective at this and that they should have been more widely used in this space.”

https://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-news-covid-vaccine-passports-cases-uk-nhs/amp/

Sona could not get their test through R&D. This is a different ball game.

Saliva might be chosen, we never know. NCYT and Vatic have offerings that, in clinic, produce OK results. Let’s wait and see. But to say AN sampling is not desired, is lies and manipulation.

iPhone - STOP with this message. Your are so irritating.

Agent - no it doesn’t. He’s a menace.

What else, other than Chinese branded tests are succeeding in the current market? Why did Mologic fail PD? Why couldn’t ODX sell Vistect? The answers to these questions are above management consultants.

Flogging a dead horse?? The horse is non-existent. You must flog this 5 times/day.

Will never, ever understand why people turn philanthropic share advisers. Why is he wasting his time posting this rhubarb?

Truth - Not sure how many times you can say Avacta are ‘bad’?

You’re essentially saying you have no faith in Affimers, or Avacta’s ability to market them. Suggest you should not be invested in a company that puts some much faith in Affimers.

Far from unseating? You mean, they haven’t done in the 7 years to date.

They have delivered a Covid test, you’re right. But at the same time proven that Affimers outperform the Abs tool of choice.

He’s fuming Timster.

It’s such a fickle system. The data has no credibility. Test-to-realease will bring harmony.

Don’t apologise, it’s hardly a crime.

Vegas - he feels it his duty to call him out for some reason. Both him and StickyStock have an unhealthy obsession with a stock they don’t own.

He blocks everyone that would normally respond… he’s a first rate mental case.

But the short term justification is a moving target. Will you get over your own bitterness. If I were Myles, I’d be worried.

Reminds of the Alan Partridge sketch when the lunatic fan has a shrine to Partridge in his front room. Yes - from now on, my vision of Ndn is no longer that weird creature he portrays himself as on Twitter, but the obsessive fan on Alan Partridge.

Ndn - your obsession with Myles is ridiculous. His investment case hasn’t changed, only the timeline. I’m sure he’s as/more frustrated than us.

Zero chance he’ll buy any part of Avacta. I’ve said before - what’s the point? Even using Affimers seems a stretch to me. But plausible nonetheless. The ethical nature of them adds true value to their business.